OCC 2022:PIANO评分在急性心肌梗死预后评估和指导急诊PCI术血栓抽吸中的临床价值

2022-05-25 梅斯医学整理 梅斯医学整理

对于急性心肌梗死行急诊PCI术的患者,PIANO评分存在一定的预后价值。另外,PIANO评分可能有助于指导急诊PCI术中血栓抽吸。

在既往研究中,科学家们建立了一种急诊PCI术中无复流现象发生的预测评分系统-PIANO评分。来自复旦大学附属中山医院心内科团队,进一步探究了PIANO评分在急性心肌梗死预后评估和指导急诊PCI血栓抽吸中的临床价值。

研究人员收纳了来自2009年至2018年于我院心内科行急诊PCI术的急性心肌梗死患者,并进行临床随访。终点事件定义为术后2年的全因死亡。通过Cox比例风险模式探究PIANO评分和临床预后的关系,并采用倾向评分校正混杂因素的作用。采用限制性立方样条图评估PIANO评分的大小和随访2年全因死亡率之间的关系。

结果显示:在入组2312例患者中,其中52.3%有高(≥8分)PIANO评分。术后随访2年,高PIANO评分患者更容易发生全因死亡,尤其是在第1个月。限制性立方样条图分析表明,PIANO评分的大小和随访2年全因死亡率之间存在线性关系。

进一步分析表明,在总体人群或存在可见血栓、高血栓负荷、血管比塞的人群中,采用血栓抽吸均未改善临床预后。然而,在高PIANO评分的人群中采用血栓抽吸,可明显改善临床预后。

总之,对于急性心肌梗死行急诊PCI术的患者,PIANO评分存在一定的预后价值。另外,PIANO评分可能有助于指导急诊PCI术中血栓抽吸。

资料来源:2022 16届东方心脏病学会议

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1633873, encodeId=733716338e304, content=<a href='/topic/show?id=578d13843ad' target=_blank style='color:#2F92EE;'>#PCI术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13843, encryptionId=578d13843ad, topicName=PCI术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea4322051797, createdName=zxl736, createdTime=Tue Mar 14 15:54:50 CST 2023, time=2023-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993553, encodeId=c1dc19935536e, content=<a href='/topic/show?id=440a226e6c4' target=_blank style='color:#2F92EE;'>#临床价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22676, encryptionId=440a226e6c4, topicName=临床价值)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Wed Sep 21 21:54:50 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641504, encodeId=e43216415045b, content=<a href='/topic/show?id=2ac589111f5' target=_blank style='color:#2F92EE;'>#血栓抽吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89111, encryptionId=2ac589111f5, topicName=血栓抽吸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975022829100, createdName=12498ca5m90暂无昵称, createdTime=Thu Nov 10 19:54:50 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748499, encodeId=4f6a1e4849931, content=<a href='/topic/show?id=962552538d4' target=_blank style='color:#2F92EE;'>#急诊PCI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52538, encryptionId=962552538d4, topicName=急诊PCI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ec436148053, createdName=slcumt, createdTime=Tue Aug 23 20:54:50 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743557, encodeId=c4ff1e43557c0, content=<a href='/topic/show?id=89691002006b' target=_blank style='color:#2F92EE;'>#预后评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100200, encryptionId=89691002006b, topicName=预后评估)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d4335139306, createdName=yeye5224624, createdTime=Sun Dec 04 12:54:50 CST 2022, time=2022-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353165, encodeId=8dd61353165a3, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri May 27 07:54:50 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
    2023-03-14 zxl736
  2. [GetPortalCommentsPageByObjectIdResponse(id=1633873, encodeId=733716338e304, content=<a href='/topic/show?id=578d13843ad' target=_blank style='color:#2F92EE;'>#PCI术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13843, encryptionId=578d13843ad, topicName=PCI术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea4322051797, createdName=zxl736, createdTime=Tue Mar 14 15:54:50 CST 2023, time=2023-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993553, encodeId=c1dc19935536e, content=<a href='/topic/show?id=440a226e6c4' target=_blank style='color:#2F92EE;'>#临床价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22676, encryptionId=440a226e6c4, topicName=临床价值)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Wed Sep 21 21:54:50 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641504, encodeId=e43216415045b, content=<a href='/topic/show?id=2ac589111f5' target=_blank style='color:#2F92EE;'>#血栓抽吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89111, encryptionId=2ac589111f5, topicName=血栓抽吸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975022829100, createdName=12498ca5m90暂无昵称, createdTime=Thu Nov 10 19:54:50 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748499, encodeId=4f6a1e4849931, content=<a href='/topic/show?id=962552538d4' target=_blank style='color:#2F92EE;'>#急诊PCI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52538, encryptionId=962552538d4, topicName=急诊PCI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ec436148053, createdName=slcumt, createdTime=Tue Aug 23 20:54:50 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743557, encodeId=c4ff1e43557c0, content=<a href='/topic/show?id=89691002006b' target=_blank style='color:#2F92EE;'>#预后评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100200, encryptionId=89691002006b, topicName=预后评估)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d4335139306, createdName=yeye5224624, createdTime=Sun Dec 04 12:54:50 CST 2022, time=2022-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353165, encodeId=8dd61353165a3, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri May 27 07:54:50 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1633873, encodeId=733716338e304, content=<a href='/topic/show?id=578d13843ad' target=_blank style='color:#2F92EE;'>#PCI术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13843, encryptionId=578d13843ad, topicName=PCI术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea4322051797, createdName=zxl736, createdTime=Tue Mar 14 15:54:50 CST 2023, time=2023-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993553, encodeId=c1dc19935536e, content=<a href='/topic/show?id=440a226e6c4' target=_blank style='color:#2F92EE;'>#临床价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22676, encryptionId=440a226e6c4, topicName=临床价值)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Wed Sep 21 21:54:50 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641504, encodeId=e43216415045b, content=<a href='/topic/show?id=2ac589111f5' target=_blank style='color:#2F92EE;'>#血栓抽吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89111, encryptionId=2ac589111f5, topicName=血栓抽吸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975022829100, createdName=12498ca5m90暂无昵称, createdTime=Thu Nov 10 19:54:50 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748499, encodeId=4f6a1e4849931, content=<a href='/topic/show?id=962552538d4' target=_blank style='color:#2F92EE;'>#急诊PCI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52538, encryptionId=962552538d4, topicName=急诊PCI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ec436148053, createdName=slcumt, createdTime=Tue Aug 23 20:54:50 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743557, encodeId=c4ff1e43557c0, content=<a href='/topic/show?id=89691002006b' target=_blank style='color:#2F92EE;'>#预后评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100200, encryptionId=89691002006b, topicName=预后评估)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d4335139306, createdName=yeye5224624, createdTime=Sun Dec 04 12:54:50 CST 2022, time=2022-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353165, encodeId=8dd61353165a3, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri May 27 07:54:50 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1633873, encodeId=733716338e304, content=<a href='/topic/show?id=578d13843ad' target=_blank style='color:#2F92EE;'>#PCI术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13843, encryptionId=578d13843ad, topicName=PCI术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea4322051797, createdName=zxl736, createdTime=Tue Mar 14 15:54:50 CST 2023, time=2023-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993553, encodeId=c1dc19935536e, content=<a href='/topic/show?id=440a226e6c4' target=_blank style='color:#2F92EE;'>#临床价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22676, encryptionId=440a226e6c4, topicName=临床价值)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Wed Sep 21 21:54:50 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641504, encodeId=e43216415045b, content=<a href='/topic/show?id=2ac589111f5' target=_blank style='color:#2F92EE;'>#血栓抽吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89111, encryptionId=2ac589111f5, topicName=血栓抽吸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975022829100, createdName=12498ca5m90暂无昵称, createdTime=Thu Nov 10 19:54:50 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748499, encodeId=4f6a1e4849931, content=<a href='/topic/show?id=962552538d4' target=_blank style='color:#2F92EE;'>#急诊PCI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52538, encryptionId=962552538d4, topicName=急诊PCI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ec436148053, createdName=slcumt, createdTime=Tue Aug 23 20:54:50 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743557, encodeId=c4ff1e43557c0, content=<a href='/topic/show?id=89691002006b' target=_blank style='color:#2F92EE;'>#预后评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100200, encryptionId=89691002006b, topicName=预后评估)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d4335139306, createdName=yeye5224624, createdTime=Sun Dec 04 12:54:50 CST 2022, time=2022-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353165, encodeId=8dd61353165a3, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri May 27 07:54:50 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
    2022-08-23 slcumt
  5. [GetPortalCommentsPageByObjectIdResponse(id=1633873, encodeId=733716338e304, content=<a href='/topic/show?id=578d13843ad' target=_blank style='color:#2F92EE;'>#PCI术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13843, encryptionId=578d13843ad, topicName=PCI术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea4322051797, createdName=zxl736, createdTime=Tue Mar 14 15:54:50 CST 2023, time=2023-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993553, encodeId=c1dc19935536e, content=<a href='/topic/show?id=440a226e6c4' target=_blank style='color:#2F92EE;'>#临床价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22676, encryptionId=440a226e6c4, topicName=临床价值)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Wed Sep 21 21:54:50 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641504, encodeId=e43216415045b, content=<a href='/topic/show?id=2ac589111f5' target=_blank style='color:#2F92EE;'>#血栓抽吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89111, encryptionId=2ac589111f5, topicName=血栓抽吸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975022829100, createdName=12498ca5m90暂无昵称, createdTime=Thu Nov 10 19:54:50 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748499, encodeId=4f6a1e4849931, content=<a href='/topic/show?id=962552538d4' target=_blank style='color:#2F92EE;'>#急诊PCI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52538, encryptionId=962552538d4, topicName=急诊PCI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ec436148053, createdName=slcumt, createdTime=Tue Aug 23 20:54:50 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743557, encodeId=c4ff1e43557c0, content=<a href='/topic/show?id=89691002006b' target=_blank style='color:#2F92EE;'>#预后评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100200, encryptionId=89691002006b, topicName=预后评估)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d4335139306, createdName=yeye5224624, createdTime=Sun Dec 04 12:54:50 CST 2022, time=2022-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353165, encodeId=8dd61353165a3, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri May 27 07:54:50 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1633873, encodeId=733716338e304, content=<a href='/topic/show?id=578d13843ad' target=_blank style='color:#2F92EE;'>#PCI术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13843, encryptionId=578d13843ad, topicName=PCI术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea4322051797, createdName=zxl736, createdTime=Tue Mar 14 15:54:50 CST 2023, time=2023-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993553, encodeId=c1dc19935536e, content=<a href='/topic/show?id=440a226e6c4' target=_blank style='color:#2F92EE;'>#临床价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22676, encryptionId=440a226e6c4, topicName=临床价值)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Wed Sep 21 21:54:50 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641504, encodeId=e43216415045b, content=<a href='/topic/show?id=2ac589111f5' target=_blank style='color:#2F92EE;'>#血栓抽吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89111, encryptionId=2ac589111f5, topicName=血栓抽吸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975022829100, createdName=12498ca5m90暂无昵称, createdTime=Thu Nov 10 19:54:50 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748499, encodeId=4f6a1e4849931, content=<a href='/topic/show?id=962552538d4' target=_blank style='color:#2F92EE;'>#急诊PCI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52538, encryptionId=962552538d4, topicName=急诊PCI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ec436148053, createdName=slcumt, createdTime=Tue Aug 23 20:54:50 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743557, encodeId=c4ff1e43557c0, content=<a href='/topic/show?id=89691002006b' target=_blank style='color:#2F92EE;'>#预后评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100200, encryptionId=89691002006b, topicName=预后评估)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d4335139306, createdName=yeye5224624, createdTime=Sun Dec 04 12:54:50 CST 2022, time=2022-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353165, encodeId=8dd61353165a3, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri May 27 07:54:50 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
    2022-05-27 zhaojie88

相关资讯

OCC 2022丨华语国际论坛:聚世界华人“心”力量,筑中华医学“心”未来

由上海市医学会、上海市医学会心血管病分会主办的第十六届东方心脏病学会议(OCC 2022)将于2022年5月25日-5月29日以全线上的形式举办。

OCC 2022:代谢正常肥胖者亚临床心脏结构,功能和组织学改变研究

尽管传统收缩功能指标LVEF在正常范围之内,MHO患者存在亚临床的心脏重构,左室收缩功能损害及心肌纤维化改变。早期识别心脏亚临床损伤有助于MHO人群心衰的预防和早期干预。

OCC 2022丨人工智能和互联网医疗论坛:从可穿戴设备到数字疗法,四大板块贯穿全生命周期

由上海市医学会、上海市医学会心血管病分会主办的第十六届东方心脏病学会议(OCC 2022)将于2022年5月25日~5月29日以线上形式举办。无论身在何处,东方会与您,不见不散!